Thus, concordant with prohibitin expression observed in tumor cell lines (Figure 1), PHB1 and PHB2 are overexpressed in lymphoid (T- and B-cell leukemia/lymphoma) and myeloid (CML) primary patient tumor cells. The gene discussed is PHB2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.